Myant Expands Precision Medicine Reach by Acquiring mmHg Inc.
Deal News | Jan 06, 2025 | PR Newswire Cision Myant Corp.
Myant Corp., a leader in chronic disease prevention and precision medicine, announced its acquisition of mmHg Inc., a digital health company specializing in remote monitoring for cardiovascular care. This strategic move expands Myant's reach into the U.S. market, leveraging mmHg's customer base and partnership with A&D Medical. MmHg's platform, known for managing cardiovascular health remotely, is used by top North American healthcare institutions. The acquisition is part of Myant's mission to drive a new era of AI-enabled remote healthcare, combining its material and textile technology with mmHg's software. This integration aims to deliver personalized healthcare with continuous, real-time data, thereby enhancing early disease detection, reducing hospital visits, and improving patient outcomes. Myant's CEO, Tony Chahine, emphasized the company's commitment to making healthy aging a reality through comprehensive cardiovascular monitoring solutions.
Sectors
- Healthcare Technology
- Digital Health
Geography
- Canada – Myant Corp. is based in Toronto, indicating significant operations within Canada.
- United States – The acquisition of mmHg Inc. aids Myant's expansion into the U.S. market, where mmHg holds a substantial customer base.
- North America – The article highlights the use of mmHg's platform across North American healthcare institutions.
Industry
- Healthcare Technology – The article involves Myant and mmHg Inc., companies focused on remote healthcare and precision medicine technologies.
- Digital Health – MmHg Inc. specializes in digital solutions for cardiovascular monitoring, enhancing remote management of health conditions.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Myant Corp. | Acquiring Company | Company | A leader in chronic disease prevention using precision medicine and AI-enabled technologies. |
| mmHg Inc. | Target Company | Company | A digital health company specializing in remote monitoring and management of cardiovascular conditions. |
| Tony Chahine | CEO | Person | CEO of Myant Corp., driving the company's mission in healthcare innovation. |
| Peter Wood | COO | Person | Co-founder and Chief Operating Officer at mmHg Inc., involved in the creation of their software platform. |
| A&D Medical | Partner Company | Company | A significant partner of mmHg Inc. in manufacturing medical devices and health products. |
| Beth Israel Deaconess (Harvard Medical), Johns Hopkins, Columbia University, NYU, Tulane University, University of British Columbia | Institutional Users | Organizations | Institutions utilizing mmHg's platform for cardiovascular health management and clinical research. |